A drug that can dramatically delay the progress of motor neurone disease (MND) will not be made available on the NHS because not enough people can benefit from it. A drug that can dramatically delay the progress of motor neurone disease (MND) will not be made available on the NHS because not enough people can benefit from it.
A breakthrough drug dramatically slows the progress of motor neurone diease. So why on earth won’t the NHS pay for it?
